Lithium Carbonate and Tretinoin in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
Status:
Completed
Trial end date:
2015-11-13
Target enrollment:
Participant gender:
Summary
This phase I trial studies the side effects and best dose of tretinoin when given together
with lithium carbonate in treating patients with relapsed or refractory acute myeloid
leukemia. Lithium carbonate may stop the growth of cancer cells by blocking some of the
enzymes needed for cell growth. Tretinoin may help [type of cancer] cells become more like
normal cells, and to grow and spread more slowly. Giving lithium carbonate together with
tretinoin may kill more cancer cells